• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by OSR Holdings Inc.

    5/15/25 5:17:55 PM ET
    $OSRH
    Medical/Dental Instruments
    Health Care
    Get the next $OSRH alert in real time by email
    NT 10-Q 1 ea0242429-nt10q_osr.htm NOTIFICATION OF LATE FILING

     

     

      OMB APPROVAL
      UNITED STATES OMB Number:3235-0058
      SECURITIES AND EXCHANGE COMMISSION Expires:      May 31, 2025
     

    Washington, D.C. 20549

     

    Estimated average burden hours per response 2.50

      FORM 12b-25

    SEC FILE NUMBER

     001-41390

        CUSIP NUMBER
      NOTIFICATION OF LATE FILING

    68840D102

     

     

    (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K  
      ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR

     

      For Period Ended: March 31, 2025   

     

    ☐Transition Report on Form 10-K
    ☐Transition Report on Form 20-F
    ☐Transition Report on Form 11-K
    ☐Transition Report on Form 10-Q

     

      For the Transition Period Ended: _____________

     

     

     

    Read Instruction (on back page) Before Preparing Form. Please Print or Type.

    Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

     

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

     

     

    PART I — REGISTRANT INFORMATION

     

    OSR HOLDINGS, INC.

     

    Full Name of Registrant

     

     

     

    Former Name if Applicable

     

    10900 NE 4th Street, Suite 2300

     

    Address of Principal Executive Office (Street and Number)

     

    Bellevue, WA 98004

     

    City, State and Zip Code

     

     

     

    PART II — RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     

      (a)  The reasons described in reasonable detail in Part III of this form could not be eliminated without  unreasonable effort or expense;
         
    ☒ (b)  The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
         
      (c) The accountant's statement or other exhibit required by Rule 12(b)-25(c) has been attached if applicable.

     

    PART III - NARRATIVE

     

    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

     

    OSR Holdings, Inc. (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 (the “Form 10-Q”) within the prescribed time period without unreasonable effort or expense. The Company has experienced a delay in completing the necessary disclosures and finalizing its financial statements with its independent registered public accounting firm in connection with its Form 10-Q. The Company anticipates that the Form 10-Q will be filed on or before the fifth calendar day following the prescribed due date.

     

    PART IV — OTHER INFORMATION

    (1)Name and telephone number of person to contact in regard to this notification

     

      Kuk Hyoun Hwang   (425)   635-7700
      Name   Area Code    Telephone Number

     

    (2)Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). ☒ Yes ☐ No

     

    (3)Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☒ Yes ☐ No
      
     

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

    The Company expects to report a significant change in results of operations for the three months ended March 31, 2025, compared to the corresponding period in the prior fiscal year. This change is primarily attributable to the completion of the Business Combination on February 14, 2025, pursuant to which OSR Holdings, Inc., formerly a special purpose acquisition company (SPAC), acquired OSR Co., Ltd. For accounting purposes, OSR Co., Ltd. is deemed the accounting acquirer, as determined in accordance with ASC 805-10.

     

    As a result, the financial statements for the current period reflect the consolidated operations of OSR Co., Ltd. and its subsidiaries. For comparability purposes, the financial results for the three months ended March 31, 2024 will be restated on the same basis to reflect the operations of OSR Co., Ltd. as the accounting acquirer. These figures differ from the historical financial statements previously filed by the SPAC, and should not be directly compared to those prior filings.

     

    The Company expects to report a consolidated net loss of approximately $11.4 million (KRW 16.5 billion) for the quarter ended March 31, 2025, compared to a restated net loss of approximately $3.1 million (KRW 4.5 billion) for the same period in 2024.1 The increase in net loss is primarily due to a significant rise in other expenses, including one-time charges related to the Business Combination.

     

    The amounts reported above for the quarter ended March 31, 2025 are still under review by the Company’s independent registered public accounting firm and accounting staff and may differ once reported in the Form 10-Q to be filed by the Company.

     

     

    1The financial results of the Company’s Korean subsidiary operations are measured in Korean Won (KRW), the functional currency of those operations.
      
     The Company believes that the exchange rate applied provides a reasonable approximation of the effects of currency translation on its interim results.

     

     

     

    OSR HOLDINGS, INC.

    (Name of Registrant as Specified in Charter)

     

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: May 15, 2025   By: /s/ Kuk Hyoun Hwang
       

    Kuk Hyoun Hwang

    Chief Executive Officer

     

    INSTRUCTION: The Form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the Form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the Form.

     

    ATTENTION

     

    INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001).

     

     

     

     

    Get the next $OSRH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $OSRH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $OSRH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • OSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH Token

      SEOUL, South Korea and ZUG, Switzerland, May 22, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ:OSRH), a public company dedicated to advancing innovation in healthcare and wellness, announced today that it has entered into a Memorandum of Understanding (MOU) with BCM Europe AG, its major shareholder, and Taekwondo Cooperative (TKD Coop), a global Taekwondo community organization, to explore the joint development of a security token, provisionally named the "OSRH Token". The initiative aims to enhance access to crypto-based liquidity and provide a basis for OSRH to launch crypto treasury strategies.

      5/22/25 7:36:00 AM ET
      $BLAC
      $OSRH
      Blank Checks
      Finance
      Medical/Dental Instruments
      Health Care
    • Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics

      PHILADELPHIA, May 2, 2025 /PRNewswire/ -- Darnatein, a subsidiary of OSR Holdings, Inc. (NASDAQ:OSRH), a biotechnology company advancing design-augmented biologics, announced today that it will present scientific data at the 14th International Bone Morphogenetic Protein (BMP) Conference, taking place May 2–6, 2025, at the University of Pennsylvania in Philadelphia. The BMP Conference brings together leading global researchers to explore the latest breakthroughs in BMP-related biology and regenerative medicine. This year's program highlights novel technologies and fundamental r

      5/2/25 7:30:00 AM ET
      $OSRH
      Medical/Dental Instruments
      Health Care
    • Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology

      SEOUL, South Korea, April 9, 2025 /PRNewswire/ -- Darnatein, a wholly-owned subsidiary of OSR Holdings, Inc. (NASDAQ:OSRH), today announces that it has successfully secured an additional international patent for its protein-based osteoarthritis treatment technology, marking a significant step in its expansion into the global market. Activin/BMP7 Chimera Protein Technology Registered in China Darnatein has officially registered a patent with the China National Intellectual Property Administration (CNIPA) for the core technology behind its break-through disease-modifying osteoar

      4/9/25 7:54:00 AM ET
      $OSRH
      Medical/Dental Instruments
      Health Care

    $OSRH
    Leadership Updates

    Live Leadership Updates

    See more
    • OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer

      BASEL, Switzerland, March 25, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ:OSRH), a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for people and their families, today announced the appointment of Dr. Constance Höfer as its new Chief Scientific Officer (CSO). Dr. Höfer, a seasoned leader in drug development with over 20 years of experience in oncology and immunology, will oversee OSR Holdings' scientific strategy and innovation pipeline. Dr. Höfer joins OSR Holdings from Merck Healthcare, where she led global programs spanning from preclinical to late-stage clinical development. Prior to Merck, she held senior leadership positions a

      3/25/25 7:00:00 AM ET
      $OSRH
      Medical/Dental Instruments
      Health Care

    $OSRH
    SEC Filings

    See more
    • SEC Form 10-Q filed by OSR Holdings Inc.

      10-Q - OSR Holdings, Inc. (0001840425) (Filer)

      5/20/25 4:00:55 PM ET
      $OSRH
      Medical/Dental Instruments
      Health Care
    • SEC Form NT 10-Q filed by OSR Holdings Inc.

      NT 10-Q - OSR Holdings, Inc. (0001840425) (Filer)

      5/15/25 5:17:55 PM ET
      $OSRH
      Medical/Dental Instruments
      Health Care
    • OSR Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - OSR Holdings, Inc. (0001840425) (Filer)

      5/12/25 4:05:17 PM ET
      $OSRH
      Medical/Dental Instruments
      Health Care